Till sidinnehåll

Referenser

Ahlen, J., Karlsson, F., Wejde, J., Nilsson, I. L., Larsson, C., & Branstrom, R. (2018). Wide Surgical Margin Improves the Outcome for Patients with Gastrointestinal Stromal Tumors (GISTs). World J Surg, 42(8), 2512-2521. https://doi.org/10.1007/s00268-018-4498-9 

Almond, L. M., Gronchi, A., Strauss, D., Jafri, M., Ford, S., & Desai, A. (2018). Neoadjuvant and adjuvant strategies in retroperitoneal sarcoma. Eur J Surg Oncol, 44(5), 571-579. https://doi.org/10.1016/j.ejso.2018.02.001 

Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., Fearon, K., Hutterer, E., Isenring, E., Kaasa, S., Krznaric, Z., Laird, B., Larsson, M., Laviano, A., Muhlebach, S., Muscaritoli, M., Oldervoll, L., Ravasco, P., Solheim, T., Strasser, F., de van der Schueren, M., & Preiser, J. C. (2017). ESPEN guidelines on nutrition in cancer patients. Clin Nutr, 36(1), 11-48. https://doi.org/10.1016/j.clnu.2016.07.015 

Baldini, E. H., Abrams, R. A., Bosch, W., Roberge, D., Haas, R. L. M., Catton, C. N., Indelicato, D. J., Olsen, J. R., Deville, C., Chen, Y. L., Finkelstein, S. E., DeLaney, T. F., & Wang, D. (2015). Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation Oncologists. Int J Radiat Oncol Biol Phys, 92(5), 1053-1059. https://doi.org/10.1016/j.ijrobp.2015.04.039 

Baldini, E. H., Bosch, W., Kane, J. M., 3rd, Abrams, R. A., Salerno, K. E., Deville, C., Raut, C. P., Petersen, I. A., Chen, Y. L., Mullen, J. T., Millikan, K. W., Karakousis, G., Kendrick, M. L., DeLaney, T. F., & Wang, D. (2015). Retroperitoneal sarcoma (RPS) high risk gross tumor volume boost (HR GTV boost) contour delineation agreement among NRG sarcoma radiation and surgical oncologists. Ann Surg Oncol, 22(9), 2846-2852. https://doi.org/10.1245/s10434-015-4633-x 

Baldini, E. H., Wang, D., Haas, R. L., Catton, C. N., Indelicato, D. J., Kirsch, D. G., Roberge, D., Salerno, K., Deville, C., Guadagnolo, B. A., O'Sullivan, B., Petersen, I. A., Le Pechoux, C., Abrams, R. A., & DeLaney, T. F. (2015). Treatment Guidelines for Preoperative Radiation Therapy for Retroperitoneal Sarcoma: Preliminary Consensus of an International Expert Panel. Int J Radiat Oncol Biol Phys, 92(3), 602-612. https://doi.org/10.1016/j.ijrobp.2015.02.013 

Ballinger, M. L., Goode, D. L., Ray-Coquard, I., James, P. A., Mitchell, G., Niedermayr, E., Puri, A., Schiffman, J. D., Dite, G. S., Cipponi, A., Maki, R. G., Brohl, A. S., Myklebost, O., Stratford, E. W., Lorenz, S., Ahn, S. M., Ahn, J. H., Kim, J. E., Shanley, S., Beshay, V., Randall, R. L., Judson, I., Seddon, B., Campbell, I. G., Young, M. A., Sarin, R., Blay, J. Y., O'Donoghue, S. I., & Thomas, D. M. (2016). Monogenic and polygenic determinants of sarcoma risk: an international genetic study. Lancet Oncol, 17(9), 1261-1271. https://doi.org/10.1016/s1470-2045(16)30147-4 

Barncancerfonden. (2017). Vårdplaneringsgruppen för Solida Tumörer hos Barn (VSTB). Retrieved 2020-10-08 from https://www.barncancerfonden.se/for-forskare/forskningsinfrastruktur/vstb---vardplaneringsgruppen-for-solida-tumorer-hos-barn/

Bauer, H. C., Trovik, C. S., Alvegard, T. A., Berlin, O., Erlanson, M., Gustafson, P., Klepp, R., Moller, T. R., Rydholm, A., Saeter, G., Wahlstrom, O., & Wiklund, T. (2001). Monitoring referral and treatment in soft tissue sarcoma: study based on 1,851 patients from the Scandinavian Sarcoma Group Register. Acta Orthop Scand, 72(2), 150-159. https://doi.org/10.1080/000164701317323408 

Bay, J.-O., Ray-Coquard, I., Fayette, J., Leyvraz, S., Cherix, S., Piperno-Neumann, S., Chevreau, C., Isambert, N., Brain, E., Emile, G., Le Cesne, A., Cioffi, A., Kwiatkowski, F., Coindre, J.-M., Bui, N. B., Peyrade, F., Blay, J.-Y., & Français, f. t. G. S. (2006). Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: A retrospective analysis. 119(3), 706-711. https://doi.org/10.1002/ijc.21867 

Beckmann, M. W., Juhasz-Boss, I., Denschlag, D., Gass, P., Dimpfl, T., Harter, P., Mallmann, P., Renner, S. P., Rimbach, S., Runnebaum, I., Untch, M., Brucker, S. Y., & Wallwiener, D. (2015). Surgical Methods for the Treatment of Uterine Fibroids - Risk of Uterine Sarcoma and Problems of Morcellation: Position Paper of the DGGG. Geburtshilfe Frauenheilkd, 75(2), 148-164. https://doi.org/10.1055/s-0035-1545684 

Benson, C., & Miah, A. B. (2017). Uterine sarcoma - current perspectives. Int J Womens Health, 9, 597-606. https://doi.org/10.2147/ijwh.s117754 

Bevilacqua, R. G., Rogatko, A., Hajdu, S. I., & Brennan, M. F. (1991). Prognostic factors in primary retroperitoneal soft-tissue sarcomas. Arch Surg, 126(3), 328-334. https://doi.org/10.1001/archsurg.1991.01410270072012 

Blackmon, S. H., Shah, N., Roth, J. A., Correa, A. M., Vaporciyan, A. A., Rice, D. C., Hofstetter, W., Walsh, G. L., Benjamin, R., Pollock, R., Swisher, S. G., & Mehran, R. (2009). Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival. Ann Thorac Surg, 88(3), 877-884; discussion 884-875. https://doi.org/10.1016/j.athoracsur.2009.04.144 

Bonvalot, S., Gronchi, A., Le Péchoux, C., Swallow, C. J., Strauss, D., Meeus, P., van Coevorden, F., Stoldt, S., Stoeckle, E., Rutkowski, P., Rastrelli, M., Raut, C. P., Hompes, D., De Paoli, A., Sangalli, C., Honoré, C., Chung, P., Miah, A., Blay, J. Y., Fiore, M., Stelmes, J. J., Dei Tos, A. P., Baldini, E. H., Litière, S., Marreaud, S., Gelderblom, H., & Haas, R. L. (2020). Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol, 21(10), 1366-1377. https://doi.org/10.1016/s1470-2045(20)30446-0

Borgfeldt, C., & Andolf, E. (2000). Transvaginal ultrasonographic findings in the uterus and the endometrium: low prevalence of leiomyoma in a random sample of women age 25-40 years. Acta Obstet Gynecol Scand, 79(3), 202-207. 

Bradley, K. A., Rubinsky, A. D., Sun, H., Bryson, C. L., Bishop, M. J., Blough, D. K., Henderson, W. G., Maynard, C., Hawn, M. T., Tonnesen, H., Hughes, G., Beste, L. A., Harris, A. H., Hawkins, E. J., Houston, T. K., & Kivlahan, D. R. (2011). Alcohol screening and risk of postoperative complications in male VA patients undergoing major non-cardiac surgery. J Gen Intern Med, 26(2), 162-169. https://doi.org/10.1007/s11606-010-1475-x 

Brennan, B., Kirton, L., Marec-Berard, P., Martin -Broto, J., Gelderblom, H., Gaspar, N., Strauss, S. J., Sastre Urgelles, A., Anderton, J., Laurence, V., Whelan, J., & Wheatley, K. (2020). Comparison of two chemotherapy regimens in Ewing sarcoma (ES): Overall and subgroup results of the Euro Ewing 2012 randomized trial (EE2012). Journal of Clinical Oncology, 38(15_suppl), 11500-11500. https://doi.org/10.1200/JCO.2020.38.15_suppl.11500

Bucher, P., Egger, J. F., Gervaz, P., Ris, F., Weintraub, D., Villiger, P., Buhler, L. H., & Morel, P. (2006). An audit of surgical management of gastrointestinal stromal tumours (GIST). Eur J Surg Oncol, 32(3), 310-314. https://doi.org/10.1016/j.ejso.2005.11.021 

Bumming, P., Andersson, J., Meis-Kindblom, J. M., Klingenstierna, H., Engstrom, K., Stierner, U., Wangberg, B., Jansson, S., Ahlman, H., Kindblom, L. G., & Nilsson, B. (2003). Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients. Br J Cancer, 89(3), 460-464. https://doi.org/10.1038/sj.bjc.6600965 

Casali, P. G., Abecassis, N., Bauer, S., Biagini, R., Bielack, S., Bonvalot, S., Boukovinas, I., Bovee, J., Brodowicz, T., Broto, J. M., Buonadonna, A., De Alava, E., Dei Tos, A. P., Del Muro, X. G., Dileo, P., Eriksson, M., Fedenko, A., Ferraresi, V., Ferrari, A., Ferrari, S., Frezza, A. M., Gasperoni, S., Gelderblom, H., Gil, T., Grignani, G., Gronchi, A., Haas, R. L., Hannu, A., Hassan, B., Hohenberger, P., Issels, R., Joensuu, H., Jones, R. L., Judson, I., Jutte, P., Kaal, S., Kasper, B., Kopeckova, K., Krakorova, D. A., Le Cesne, A., Lugowska, I., Merimsky, O., Montemurro, M., Pantaleo, M. A., Piana, R., Picci, P., Piperno-Neumann, S., Pousa, A. L., Reichardt, P., Robinson, M. H., Rutkowski, P., Safwat, A. A., Schoffski, P., Sleijfer, S., Stacchiotti, S., Sundby Hall, K., Unk, M., Van Coevorden, F., Van der Graaf, W., Whelan, J., Wardelmann, E., Zaikova, O., & Blay, J. Y. (2018). Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 29(Supplement_4), iv51-iv67. https://doi.org/10.1093/annonc/mdy096 

Casali, P. G., Bielack, S., Abecassis, N., Aro, H. T., Bauer, S., Biagini, R., Bonvalot, S., Boukovinas, I., Bovee, J., Brennan, B., Brodowicz, T., Broto, J. M., Brugieres, L., Buonadonna, A., De Alava, E., Dei Tos, A. P., Del Muro, X. G., Dileo, P., Dhooge, C., Eriksson, M., Fagioli, F., Fedenko, A., Ferraresi, V., Ferrari, A., Ferrari, S., Frezza, A. M., Gaspar, N., Gasperoni, S., Gelderblom, H., Gil, T., Grignani, G., Gronchi, A., Haas, R. L., Hassan, B., Hecker-Nolting, S., Hohenberger, P., Issels, R., Joensuu, H., Jones, R. L., Judson, I., Jutte, P., Kaal, S., Kager, L., Kasper, B., Kopeckova, K., Krakorova, D. A., Ladenstein, R., Le Cesne, A., Lugowska, I., Merimsky, O., Montemurro, M., Morland, B., Pantaleo, M. A., Piana, R., Picci, P., Piperno-Neumann, S., Pousa, A. L., Reichardt, P., Robinson, M. H., Rutkowski, P., Safwat, A. A., Schoffski, P., Sleijfer, S., Stacchiotti, S., Strauss, S. J., Sundby Hall, K., Unk, M., Van Coevorden, F., van der Graaf, W. T. A., Whelan, J., Wardelmann, E., Zaikova, O., & Blay, J. Y. (2018). Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 29(Suppl 4), iv79-iv95. https://doi.org/10.1093/annonc/mdy310 

Cederholm, T., Bosaeus, I., Barazzoni, R., Bauer, J., Van Gossum, A., Klek, S., Muscaritoli, M., Nyulasi, I., Ockenga, J., Schneider, S. M., de van der Schueren, M. A., & Singer, P. (2015). Diagnostic criteria for malnutrition - An ESPEN Consensus Statement. Clin Nutr, 34(3), 335-340. https://doi.org/10.1016/j.clnu.2015.03.001 

Choudhury, A., Zhao, H., Jalali, F., Al Rashid, S., Ran, J., Supiot, S., Kiltie, A. E., & Bristow, R. G. (2009). Targeting homologous recombination using imatinib results in enhanced tumor cell chemosensitivity and radiosensitivity. Mol Cancer Ther, 8(1), 203-213. https://doi.org/10.1158/1535-7163.mct-08-0959 

Corless, C. L., Ballman, K. V., Antonescu, C. R., Kolesnikova, V., Maki, R. G., Pisters, P. W., Blackstein, M. E., Blanke, C. D., Demetri, G. D., Heinrich, M. C., von Mehren, M., Patel, S., McCarter, M. D., Owzar, K., & DeMatteo, R. P. (2014). Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial. J Clin Oncol, 32(15), 1563-1570. https://doi.org/10.1200/jco.2013.51.2046 

Demetri, G. D., Chawla, S. P., Mehren, M. v., Ritch, P., Baker, L. H., Blay, J. Y., Hande, K. R., Keohan, M. L., Samuels, B. L., Schuetze, S., Lebedinsky, C., Elsayed, Y. A., Izquierdo, M. A., Gómez, J., Park, Y. C., & Cesne, A. L. (2009). Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules. 27(25), 4188-4196. https://doi.org/10.1200/jco.2008.21.0088 

Demetri, G. D., Reichardt, P., Kang, Y. K., Blay, J. Y., Rutkowski, P., Gelderblom, H., Hohenberger, P., Leahy, M., von Mehren, M., Joensuu, H., Badalamenti, G., Blackstein, M., Le Cesne, A., Schoffski, P., Maki, R. G., Bauer, S., Nguyen, B. B., Xu, J., Nishida, T., Chung, J., Kappeler, C., Kuss, I., Laurent, D., & Casali, P. G. (2013). Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet, 381(9863), 295-302. https://doi.org/10.1016/s0140-6736(12)61857-1 

Demetri, G. D., Schöffski, P., Grignani, G., Blay, J.-Y., Maki, R. G., Tine, B. A. V., Alcindor, T., Jones, R. L., D’Adamo, D. R., Guo, M., & Chawla, S. (2017). Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine. 35(30), 3433-3439. https://doi.org/10.1200/jco.2016.71.6605 

Demetri, G. D., van Oosterom, A. T., Garrett, C. R., Blackstein, M. E., Shah, M. H., Verweij, J., McArthur, G., Judson, I. R., Heinrich, M. C., Morgan, J. A., Desai, J., Fletcher, C. D., George, S., Bello, C. L., Huang, X., Baum, C. M., & Casali, P. G. (2006). Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet, 368(9544), 1329-1338. https://doi.org/10.1016/s0140-6736(06)69446-4 

Derbel, O., Heudel, P. E., Cropet, C., Meeus, P., Vaz, G., Biron, P., Cassier, P., Decouvelaere, A. V., Ranchere-Vince, D., Collard, O., De Laroche, E., Thiesse, P., Farsi, F., Cellier, D., Gilly, F. N., Blay, J. Y., & Ray-Coquard, I. (2017). Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort). PLoS One, 12(2), e0158406. https://doi.org/10.1371/journal.pone.0158406 

Dumitra, S., & Gronchi, A. (2018). The Diagnosis and Management of Retroperitoneal Sarcoma. Oncology (Williston Park), 32(9), 464-469. 

Egholm, J. W., Pedersen, B., Moller, A. M., Adami, J., Juhl, C. B., & Tonnesen, H. (2018). Perioperative alcohol cessation intervention for postoperative complications. Cochrane Database Syst Rev, 11, Cd008343. https://doi.org/10.1002/14651858.CD008343.pub3 

Enneking, W. F., Spanier, S. S., & Goodman, M. A. (1980). A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res(153), 106-120. 

Eriksson, M., Reichardt, P., Sundby Hall, K., Schutte, J., Cameron, S., Hohenberger, P., Bauer, S., Leinonen, M., Reichardt, A., Rejmyr Davis, M., Alvegard, T., & Joensuu, H. (2016). Needle biopsy through the abdominal wall for the diagnosis of gastrointestinal stromal tumour - Does it increase the risk for tumour cell seeding and recurrence? Eur J Cancer, 59, 128-133. https://doi.org/10.1016/j.ejca.2016.02.021 

Esmo European Sarcoma Network Working Group. (2012). Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 23 Suppl 7, vii100-109. https://doi.org/10.1093/annonc/mds254 

European Partnership Action Against Cancer consensus, g., Borras, J. M., Albreht, T., Audisio, R., Briers, E., Casali, P., Esperou, H., Grube, B., Hamoir, M., Henning, G., Kelly, J., Knox, S., Nabal, M., Pierotti, M., Lombardo, C., van Harten, W., Poston, G., Prades, J., Sant, M., Travado, L., Valentini, V., van de Velde, C., van den Bogaert, S., van den Bulcke, M., van Hoof, E., van den Neucker, I., & Wilson, R. (2014). Policy statement on multidisciplinary cancer care. Eur J Cancer, 50(3), 475-480. https://doi.org/10.1016/j.ejca.2013.11.012 

European Sarcoma Network Working Group (ESMO). (2014). Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 25 Suppl 3, iii102-112. https://doi.org/10.1093/annonc/mdu254 

Farag, S., Geus-Oei, L. F., van der Graaf, W. T., van Coevorden, F., Grunhagen, D., Reyners, A. K. L., Boonstra, P. A., Desar, I., Gelderblom, H., & Steeghs, N. (2018). Early Evaluation of Response Using (18)F-FDG PET Influences Management in Gastrointestinal Stromal Tumor Patients Treated with Neoadjuvant Imatinib. J Nucl Med, 59(2), 194-196. https://doi.org/10.2967/jnumed.117.196642 

Frassanito, L., Vergari, A., Nestorini, R., Cerulli, G., Placella, G., Pace, V., & Rossi, M. (2019). Enhanced recovery after surgery (ERAS) in hip and knee replacement surgery: description of a multidisciplinary program to improve management of the patients undergoing major orthopedic surgery. Musculoskelet Surg. https://doi.org/10.1007/s12306-019-00603-4 

Gatta, G., Capocaccia, R., Botta, L., Mallone, S., De Angelis, R., Ardanaz, E., Comber, H., Dimitrova, N., Leinonen, M. K., Siesling, S., van der Zwan, J. M., Van Eycken, L., Visser, O., Zakelj, M. P., Anderson, L. A., Bella, F., Kaire, I., Otter, R., Stiller, C. A., & Trama, A. (2017). Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study. Lancet Oncol, 18(8), 1022-1039. https://doi.org/10.1016/s1470-2045(17)30445-x 

Gavamukulya, Y., El-Shemy, H. A., Meroka, A. M., Madivoli, E. S., Maina, E. N., Wamunyokoli, F., & Magoma, G. (2019). Advances in green nanobiotechnology: Data for synthesis and characterization of silver nanoparticles from ethanolic extracts of fruits and leaves of Annona muricata. Data Brief, 25, 104194. https://doi.org/10.1016/j.dib.2019.104194 

Grimer, R., Judson, I., Peake, D., & Seddon, B. (2010). Guidelines for the management of soft tissue sarcomas. Sarcoma, 2010, 506182. https://doi.org/10.1155/2010/506182 

Grünwald, V., Karch, A., Schuler, M., Schöffski, P., Kopp, H. G., Bauer, S., Kasper, B., Lindner, L. H., Chemnitz, J. M., Crysandt, M., Stein, A., Steffen, B., Richter, S., Egerer, G., Ivanyi, P., Zimmermann, S., Liu, X., & Kunitz, A. (2020). Randomized Comparison of Pazopanib and Doxorubicin as First-Line Treatment in Patients With Metastatic Soft Tissue Sarcoma Age 60 Years or Older: Results of a German Intergroup Study. J Clin Oncol, 38(30), 3555-3564. https://doi.org/10.1200/jco.20.00714

Gustafson, P. (1994). Soft tissue sarcoma. Epidemiology and prognosis in 508 patients. Acta Orthop Scand Suppl, 259, 1-31. 

Gutierrez, J. C., Perez, E. A., Moffat, F. L., Livingstone, A. S., Franceschi, D., & Koniaris, L. G. (2007). Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients. Ann Surg, 245(6), 952-958. https://doi.org/10.1097/01.sla.0000250438.04393.a8 

Haas, R. L., Baldini, E. H., Chung, P. W., van Coevorden, F., & DeLaney, T. F. (2018). Radiation therapy in retroperitoneal sarcoma management. J Surg Oncol, 117(1), 93-98. https://doi.org/10.1002/jso.24892 

Hui, E. P., Ma, B. B., King, A. D., Mo, F., Chan, S. L., Kam, M. K., Loong, H. H., Ahuja, A. T., Zee, B. C., & Chan, A. T. (2011). Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation. Ann Oncol, 22(6), 1280-1287. https://doi.org/10.1093/annonc/mdq629 

Irtan, S., Van Tinteren, H., Graf, N., van den Heuvel-Eibrink, M. M., Heij, H., Bergeron, C., de Camargo, B., Acha, T., Spreafico, F., Vujanic, G., Powis, M., Okoye, B., Wilde, J., Godzinski, J., & Pritchard-Jones, K. (2019). Evaluation of needle biopsy as a potential risk factor for local recurrence of Wilms tumour in the SIOP WT 2001 trial. Eur J Cancer, 116, 13-20. https://doi.org/10.1016/j.ejca.2019.04.027 

Iwakawa, M., Noda, S., Yamada, S., Yamamoto, N., Miyazawa, Y., Yamazaki, H., Kawakami, Y., Matsui, Y., Tsujii, H., Mizoe, J., Oda, E., Fukunaga, Y., & Imai, T. (2006). Analysis of non-genetic risk factors for adverse skin reactions to radiotherapy among 284 breast cancer patients. Breast Cancer, 13(3), 300. https://doi.org/10.2325/jbcs.13.300 

Jagsi, R., Griffith, K. A., Koelling, T., Roberts, R., & Pierce, L. J. (2007). Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early-stage breast cancer. Cancer, 109(4), 650-657. https://doi.org/10.1002/cncr.22452 

Jian, B. J., Bloch, O. G., Yang, I., Han, S. J., Aranda, D., Tihan, T., & Parsa, A. T. (2010). Adjuvant radiation therapy and chondroid chordoma subtype are associated with a lower tumor recurrence rate of cranial chordoma. J Neurooncol, 98(1), 101-108. https://doi.org/10.1007/s11060-009-0068-1 

Joensuu, H. (2008). Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol, 39(10), 1411-1419. https://doi.org/10.1016/j.humpath.2008.06.025 

Joensuu, H., Eriksson, M., Sundby Hall, K., Reichardt, A., Hartmann, J. T., Pink, D., Ramadori, G., Hohenberger, P., Al-Batran, S. E., Schlemmer, M., Bauer, S., Wardelmann, E., Nilsson, B., Sihto, H., Bono, P., Kallio, R., Junnila, J., Alvegard, T., & Reichardt, P. (2016). Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial. J Clin Oncol, 34(3), 244-250. https://doi.org/10.1200/jco.2015.62.9170 

Joensuu, H., Wardelmann, E., Sihto, H., Eriksson, M., Sundby Hall, K., Reichardt, A., Hartmann, J. T., Pink, D., Cameron, S., Hohenberger, P., Al-Batran, S. E., Schlemmer, M., Bauer, S., Nilsson, B., Kallio, R., Junnila, J., Vehtari, A., & Reichardt, P. (2017). Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial. JAMA Oncol, 3(5), 602-609. https://doi.org/10.1001/jamaoncol.2016.5751 

Johnson, G. D., Smith, G., Dramis, A., & Grimer, R. J. (2008). Delays in referral of soft tissue sarcomas. Sarcoma, 2008, 378574. https://doi.org/10.1155/2008/378574 

Judson, I., Verweij, J., Gelderblom, H., Hartmann, J. T., Schoffski, P., Blay, J. Y., Kerst, J. M., Sufliarsky, J., Whelan, J., Hohenberger, P., Krarup-Hansen, A., Alcindor, T., Marreaud, S., Litiere, S., Hermans, C., Fisher, C., Hogendoorn, P. C., dei Tos, A. P., & van der Graaf, W. T. (2014). Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. Lancet Oncol, 15(4), 415-423. https://doi.org/10.1016/s1470-2045(14)70063-4 

Kadam, P. D., & Chuan, H. H. (2016). Erratum to: Rectocutaneous fistula with transmigration of the suture: a rare delayed complication of vault fixation with the sacrospinous ligament. Int Urogynecol J, 27(3), 505. https://doi.org/10.1007/s00192-016-2952-5 

Kang, Y. K., Ryu, M. H., Yoo, C., Ryoo, B. Y., Kim, H. J., Lee, J. J., Nam, B. H., Ramaiya, N., Jagannathan, J., & Demetri, G. D. (2013). Resumption of imatinib to control metastatic or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib (RIGHT): a randomised, placebo-controlled, phase 3 trial. Lancet Oncol, 14(12), 1175-1182. https://doi.org/10.1016/s1470-2045(13)70453-4 

Karakousis, C. P., Velez, A. F., Gerstenbluth, R., & Driscoll, D. L. (1996). Resectability and survival in retroperitoneal sarcomas. Ann Surg Oncol, 3(2), 150-158. 

Kasper, B., Baumgarten, C., Bonvalot, S., Haas, R., Haller, F., Hohenberger, P., Moreau, G., van der Graaf, W. T. A., & Gronchi, A. (2015). Management of sporadic desmoid-type fibromatosis: A European consensus approach based on patients’ and professionals’ expertise – A Sarcoma Patients EuroNet and European Organisation for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group initiative. European Journal of Cancer, 51(2), 127-136. https://doi.org/10.1016/j.ejca.2014.11.005 

Kasper, B., Baumgarten, C., Garcia, J., Bonvalot, S., Haas, R., Haller, F., Hohenberger, P., Penel, N., Messiou, C., van der Graaf, W. T., Gronchi, A., & Group, D. W. (2017). An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG). Annals of Oncology, 28(10), 2399-2408. https://doi.org/10.1093/annonc/mdx323 %J Annals of Oncology 

Kaufman, E. L., Jacobson, J. S., Hershman, D. L., Desai, M., & Neugut, A. I. (2008). Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol, 26(3), 392-398. https://doi.org/10.1200/jco.2007.13.3033 

Laughlin-Tommaso, S. K., Jacoby, V. L., & Myers, E. R. (2017). Disparities in Fibroid Incidence, Prognosis, and Management. Obstet Gynecol Clin North Am, 44(1), 81-94. https://doi.org/10.1016/j.ogc.2016.11.007 

Laurent, H., Aubreton, S., Galvaing, G., Pereira, B., Merle, P., Richard, R., Costes, F., & Filaire, M. (2019). Preoperative respiratory muscle endurance training improves ventilatory capacity and prevents pulmonary postoperative complications after lung surgery: a randomized controlled trial. Eur J Phys Rehabil Med. https://doi.org/10.23736/s1973-9087.19.05781-2 

Le Cesne, A., Ray-Coquard, I., Bui, B. N., Adenis, A., Rios, M., Bertucci, F., Duffaud, F., Chevreau, C., Cupissol, D., Cioffi, A., Emile, J. F., Chabaud, S., Perol, D., & Blay, J. Y. (2010). Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial. Lancet Oncol, 11(10), 942-949. https://doi.org/10.1016/s1470-2045(10)70222-9 

Leithner, A., Schnack, B., Katterschafka, T., Wiltschke, C., Amann, G., Windhager, R., Kotz, R., & Zielinski, C. C. (2000). Treatment of extra-abdominal desmoid tumors with interferon-alpha with or without tretinoin. J Surg Oncol, 73(1), 21-25. https://www.ncbi.nlm.nih.gov/pubmed/10649274 

Lewis, J. J., Leung, D., Woodruff, J. M., & Brennan, M. F. (1998). Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg, 228(3), 355-365. 

Liles, J. S., Tzeng, C. W., Short, J. J., Kulesza, P., & Heslin, M. J. (2009). Retroperitoneal and intra-abdominal sarcoma. Curr Probl Surg, 46(6), 445-503. https://doi.org/10.1067/j.cpsurg.2009.01.004 

Lolli, C., Pantaleo, M. A., Nannini, M., Saponara, M., Pallotti, M. C., Scioscio, V. D., Barbieri, E., Mandrioli, A., & Biasco, G. (2011). Successful radiotherapy for local control of progressively increasing metastasis of gastrointestinal stromal tumor. Rare Tumors, 3(4), e49. https://doi.org/10.4081/rt.2011.e49 

Lu, Z., & Chen, J. (2014). [Introduction of WHO classification of tumours of female reproductive organs, fourth edition]. Zhonghua Bing Li Xue Za Zhi, 43(10), 649-650. 

Ludovisi, M., Moro, F., Pasciuto, T., Di Noi, S., Giunchi, S., Savelli, L., Pascual, M. A., Sladkevicius, P., Alcazar, J. L., Franchi, D., Mancari, R., Moruzzi, M. C., Jurkovic, D., Chiappa, V., Guerriero, S., Exacoustos, C., Epstein, E., Fruhauf, F., Fischerova, D., Fruscio, R., Ciccarone, F., Zannoni, G. F., Scambia, G., Valentin, L., & Testa, A. C. (2019). Imaging of gynecological disease: clinical and ultrasound characteristics of uterine sarcomas. Ultrasound Obstet Gynecol. https://doi.org/10.1002/uog.20270 

Malekzadeh, F., Rose, C., Ingvar, C., & Jernstrom, H. (2005). [Natural remedies and hormone preparations--potential risk for breast cancer patients. A study surveys the use of agents which possibly counteract with the treatment]. Lakartidningen, 102(44), 3226-3228, 3230-3221. (Naturlakemedel och hormonpreparat- potentiell risk for brostcancerpatienter. Studie kartlagger bruk av medel som kanske motverkar behandlingen.) 

Marcella, C., Shi, R. H., & Sarwar, S. (2018). Clinical Overview of GIST and Its Latest Management by Endoscopic Resection in Upper GI: A Literature Review. Gastroenterol Res Pract, 2018, 6864256. https://doi.org/10.1155/2018/6864256 

Miettinen, M., Sobin, L. H., & Lasota, J. (2005). Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol, 29(1), 52-68. 

Mir, O., Cropet, C., Toulmonde, M., Cesne, A. L., Molimard, M., Bompas, E., Cassier, P., Ray-Coquard, I., Rios, M., Adenis, A., Italiano, A., Bouche, O., Chauzit, E., Duffaud, F., Bertucci, F., Isambert, N., Gautier, J., Blay, J. Y., & Perol, D. (2016). Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial. Lancet Oncol, 17(5), 632-641. https://doi.org/10.1016/s1470-2045(16)00075-9 

Mitchell, G., Ballinger, M. L., Wong, S., Hewitt, C., James, P., Young, M. A., Cipponi, A., Pang, T., Goode, D. L., Dobrovic, A., & Thomas, D. M. (2013). High frequency of germline TP53 mutations in a prospective adult-onset sarcoma cohort. PLoS One, 8(7), e69026. https://doi.org/10.1371/journal.pone.0069026 

Murakami, M., Ichimura, T., Kasai, M., Matsuda, M., Kawamura, N., Fukuda, T., & Sumi, T. (2018). Examination of the use of needle biopsy to perform laparoscopic surgery safely on uterine smooth muscle tumors. Oncol Lett, 15(6), 8647-8651. https://doi.org/10.3892/ol.2018.8425 

Nannini, M., Biasco, G., Pallotti, M. C., Di Battista, M., Santini, D., Paterini, P., Maleddu, A., Mandrioli, A., Lolli, C., Saponara, M., Di Scioscio, V., Zompatori, M., Catena, F., Fusaroli, P., Dei Tos, A. P., & Pantaleo, M. A. (2012). Late recurrences of gastrointestinal stromal tumours (GISTs) after 5 years of follow-up. Med Oncol, 29(1), 144-150. https://doi.org/10.1007/s12032-010-9806-7 

Nath, B., Li, Y., Carroll, J. E., Szabo, G., Tseng, J. F., & Shah, S. A. (2010). Alcohol exposure as a risk factor for adverse outcomes in elective surgery. J Gastrointest Surg, 14(11), 1732-1741. https://doi.org/10.1007/s11605-010-1350-4 

Ng, E. H., Pollock, R. E., Munsell, M. F., Atkinson, E. N., & Romsdahl, M. M. (1992). Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging. Ann Surg, 215(1), 68-77. https://doi.org/10.1097/00000658-199201000-00010 

Nilsson, B., Bumming, P., Meis-Kindblom, J. M., Oden, A., Dortok, A., Gustavsson, B., Sablinska, K., & Kindblom, L. G. (2005). Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era--a population-based study in western Sweden. Cancer, 103(4), 821-829. https://doi.org/10.1002/cncr.20862 

Nussbaum, D. P., Rushing, C. N., Lane, W. O., Cardona, D. M., Kirsch, D. G., Peterson, B. L., & Blazer, D. G. R. (2016). Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database. Lancet Oncol, 17(7), 966-975. https://doi.org/10.1016/s1470-2045(16)30050-x 

Peterson, C. (2005). [Natural remedies--self care at your own risk! Danger of unknown adverse effects and interactions with "common" medications]. Lakartidningen, 102(44), 3200-3201. (Naturlakemedel--egenvard pa egen risk! Fara for okanda biverkningar och interaktioner med "vanliga" lakemedel.) 

Picci, P., Bohling, T., Bacci, G., Ferrari, S., Sangiorgi, L., Mercuri, M., Ruggieri, P., Manfrini, M., Ferraro, A., Casadei, R., Benassi, M. S., Mancini, A. F., Rosito, P., Cazzola, A., Barbieri, E., Tienghi, A., Brach del Prever, A., Comandone, A., Bacchini, P., & Bertoni, F. (1997). Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities. J Clin Oncol, 15(4), 1553-1559. https://doi.org/10.1200/jco.1997.15.4.1553 

Pillay, B., Wootten, A. C., Crowe, H., Corcoran, N., Tran, B., Bowden, P., Crowe, J., & Costello, A. J. (2016). The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: A systematic review of the literature. Cancer Treat Rev, 42, 56-72. https://doi.org/10.1016/j.ctrv.2015.11.007 

Porter, G. A., Baxter, N. N., & Pisters, P. W. (2006). Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery, and radiotherapy. Cancer, 106(7), 1610-1616. https://doi.org/10.1002/cncr.21761 

Prochazka, M., Granath, F., Ekbom, A., Shields, P. G., & Hall, P. (2002). Lung cancer risks in women with previous breast cancer. Eur J Cancer, 38(11), 1520-1525. 

Rastrelli, M., Tropea, S., Basso, U., Roma, A., Maruzzo, M., & Rossi, C. R. (2014). Soft tissue limb and trunk sarcomas: diagnosis, treatment and follow-up. Anticancer Res, 34(10), 5251-5262. https://www.ncbi.nlm.nih.gov/pubmed/25275017 

Raut, C. P., & Pisters, P. W. (2006). Retroperitoneal sarcomas: Combined-modality treatment approaches. J Surg Oncol, 94(1), 81-87. https://doi.org/10.1002/jso.20543 

Rothermundt, C., Whelan, J. S., Dileo, P., Strauss, S. J., Coleman, J., Briggs, T. W., Haile, S. R., & Seddon, B. M. (2014). What is the role of routine follow-up for localised limb soft tissue sarcomas? A retrospective analysis of 174 patients. Br J Cancer, 110(10), 2420-2426. https://doi.org/10.1038/bjc.2014.200 

Rutkowski, P., Jagielska, B., Andrzejuk, J., Bylina, E., Lugowska, I., Switaj, T., Kosela-Paterczyk, H., Kozak, K., Falkowski, S., & Klimczak, A. (2017). The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST). Contemp Oncol (Pozn), 21(4), 285-289. https://doi.org/10.5114/wo.2017.72393 

Rutkowski, P., Nowecki, Z. I., Michej, W., Debiec-Rychter, M., Wozniak, A., Limon, J., Siedlecki, J., Grzesiakowska, U., Kakol, M., Osuch, C., Polkowski, M., Gluszek, S., Zurawski, Z., & Ruka, W. (2007). Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumor. Ann Surg Oncol, 14(7), 2018-2027. https://doi.org/10.1245/s10434-007-9377-9 

Rydholm, A. (1983). Management of patients with soft-tissue tumors. Strategy developed at a regional oncology center. Acta Orthop Scand Suppl, 203, 13-77. 

Saeter, G., Hall, K. S., Bruland, O. S., Solheim, O. P., Hoie, J., Folleras, G., Helgerud, P., Stenwig, A. E., Bjerkehagen, B., Talle, K., Taksdal, I., & Winderen, M. (2002). [Bone and soft tissue sarcomas treated at the Norwegian Radium Hospital 1980-99]. Tidsskr Nor Laegeforen, 122(21), 2089-2094. (Bein- og blotvevssarkomer behandlet ved Det Norske Radiumhospital 1980-99.) 

Salzer-Kuntschik, M. (1993). [Classification and grading of soft tissue tumors]. Chirurg, 64(6), 435-442. (Klassifikation und Grading der Weichgewebstumoren.) 

Sampo, M., Tarkkanen, M., Huuhtanen, R., Tukiainen, E., Bohling, T., & Blomqvist, C. (2008). Impact of the smallest surgical margin on local control in soft tissue sarcoma. Br J Surg, 95(2), 237-243. https://doi.org/10.1002/bjs.5906 

Scandinavian Sarcoma Group Trials (SSG). (2017). Treatment Protocols and recommendations - Sarcoma. Retrieved 2020-10-08 from http://www.ssg-org.net/treatment-protocols-and-recommendations/ongoing

Schoffski, P., Reichardt, P., Blay, J. Y., Dumez, H., Morgan, J. A., Ray-Coquard, I., Hollaender, N., Jappe, A., & Demetri, G. D. (2010). A phase I-II study of everolimus (RAD001) in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors. Ann Oncol, 21(10), 1990-1998. https://doi.org/10.1093/annonc/mdq076 

Sharp, L., Johansson, H., Hatschek, T., & Bergenmar, M. (2013). Smoking as an independent risk factor for severe skin reactions due to adjuvant radiotherapy for breast cancer. Breast, 22(5), 634-638. https://doi.org/10.1016/j.breast.2013.07.047 

Socialstyrelsen. (2018). Nationella riktlinjer för prevention och behandling vid ohälsosamma levnadsvanor. Socialstyrelsen. Retrieved 2020-10-08 from https://www.socialstyrelsen.se/regler-och-riktlinjer/nationella-riktlinjer/publicerade-riktlinjer/levnadsvanor/

Stacchiotti, S., Negri, T., Libertini, M., Palassini, E., Marrari, A., De Troia, B., Gronchi, A., Dei Tos, A. P., Morosi, C., Messina, A., Pilotti, S., & Casali, P. G. (2012). Sunitinib malate in solitary fibrous tumor (SFT). Ann Oncol, 23(12), 3171-3179. https://doi.org/10.1093/annonc/mds143

Stacchiotti, S., Tamborini, E., Marrari, A., Brich, S., Rota, S. A., Orsenigo, M., Crippa, F., Morosi, C., Gronchi, A., Pierotti, M. A., Casali, P. G., & Pilotti, S. (2009). Response to sunitinib malate in advanced alveolar soft part sarcoma. Clin Cancer Res, 15(3), 1096-1104. https://doi.org/10.1158/1078-0432.Ccr-08-2050

Storm, F. K., & Mahvi, D. M. (1991). Diagnosis and management of retroperitoneal soft-tissue sarcoma. Ann Surg, 214(1), 2-10. https://doi.org/10.1097/00000658-199107000-00002 

Styring, E., Billing, V., Hartman, L., Nilbert, M., Seinen, J. M., Veurink, N., Vult von Steyern, F., & Rydholm, A. (2012). Simple guidelines for efficient referral of soft-tissue sarcomas: a population-based evaluation of adherence to guidelines and referral patterns. J Bone Joint Surg Am, 94(14), 1291-1296. https://doi.org/10.2106/jbjs.K.01271 

Temming, P., Arendt, M., Viehmann, A., Eisele, L., Le Guin, C. H., Schundeln, M. M., Biewald, E., Astrahantseff, K., Wieland, R., Bornfeld, N., Sauerwein, W., Eggert, A., Jockel, K. H., & Lohmann, D. R. (2017). Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: A report from the German reference center. Pediatr Blood Cancer, 64(1), 71-80. https://doi.org/10.1002/pbc.26193 

The Gastrointestinal Stromal Tumor Meta-Analysis Group (MetaGIST). (2010). Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors: a meta-analysis of 1,640 patients. J Clin Oncol, 28(7), 1247-1253. https://doi.org/10.1200/jco.2009.24.2099 

Thenappan, A., Halaweish, I., Mody, R. J., Smith, E. A., Geiger, J. D., Ehrlich, P. F., Jasty Rao, R., Hutchinson, R., Yanik, G., Rabah, R. M., Heider, A., Stoll, T., & Newman, E. A. (2017). Review at a multidisciplinary tumor board impacts critical management decisions of pediatric patients with cancer. Pediatr Blood Cancer, 64(2), 254-258. https://doi.org/10.1002/pbc.26201 

Tonnesen, H., Nielsen, P. R., Lauritzen, J. B., & Moller, A. M. (2009). Smoking and alcohol intervention before surgery: evidence for best practice. Br J Anaesth, 102(3), 297-306. https://doi.org/10.1093/bja/aen401 

Topal, B., Smelt, H. J. M., Van Helden, E. V., Celik, A., Verseveld, M., Smeenk, F., & Pouwels, S. (2019). Utility of preoperative exercise therapy in reducing postoperative morbidity after surgery; a clinical overview of current evidence. Expert Rev Cardiovasc Ther, 17(6), 395-412. https://doi.org/10.1080/14779072.2019.1625771 

Toulmonde, M., Bonvalot, S., Meeus, P., Stoeckle, E., Riou, O., Isambert, N., Bompas, E., Jafari, M., Delcambre-Lair, C., Saada, E., Le Cesne, A., Le Pechoux, C., Blay, J. Y., Piperno-Neumann, S., Chevreau, C., Bay, J. O., Brouste, V., Terrier, P., Ranchere-Vince, D., Neuville, A., & Italiano, A. (2014). Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group. Ann Oncol, 25(3), 735-742. https://doi.org/10.1093/annonc/mdt577 

Toulmonde, M., Pulido, M., Ray-Coquard, I., Andre, T., Isambert, N., Chevreau, C., Penel, N., Bompas, E., Saada, E., Bertucci, F., Lebbe, C., Le Cesne, A., Soulie, P., Piperno-Neumann, S., Sweet, S., Cecchi, F., Hembrough, T., Bellera, C., Kind, M., Crombe, A., Lucchesi, C., Le Loarer, F., Blay, J.-Y., & Italiano, A. (2019). Pazopanib or methotrexate–vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study. The Lancet Oncology, 20(9), 1263-1272. https://doi.org/https://doi.org/10.1016/S1470-2045(19)30276-1 

Toulmonde, M., Ray-Coquard, I. L., Pulido, M., Andre, T., Isambert, N., Chevreau, C., Penel, N., Bompas, E., Thyss, A., Bertucci, F., Lebbe, C., Domont, J., Soulie, P., Neumann, S. P., Cecchi, F., Hembrough, T. A., Petitprez, F., Bellera, C. A., Blay, J.-Y., & Italiano, A. (2018). DESMOPAZ pazopanib (PZ) versus IV methotrexate/vinblastine (MV) in adult patients with progressive desmoid tumors (DT) a randomized phase II study from the French Sarcoma Group. 36(15_suppl), 11501-11501. https://doi.org/10.1200/JCO.2018.36.15_suppl.11501 

Tran, T., Davila, J. A., & El-Serag, H. B. (2005). The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol, 100(1), 162-168. https://doi.org/10.1111/j.1572-0241.2005.40709.x 

Trans-Atlantic RPS Working Group. (2015). Management of primary retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group. Ann Surg Oncol, 22(1), 256-263. https://doi.org/10.1245/s10434-014-3965-2 

Trovik, C. S., Bauer, H. C., Alvegard, T. A., Anderson, H., Blomqvist, C., Berlin, O., Gustafson, P., Saeter, G., & Walloe, A. (2000). Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register. Eur J Cancer, 36(6), 710-716. https://doi.org/10.1016/s0959-8049(99)00287-7 

Wada, N., Takahashi, T., Kurokawa, Y., Nakajima, K., Miyazaki, Y., Makino, T., Yamasaki, M., Takiguchi, S., Masuzawa, T., Nishida, T., Mori, M., & Doki, Y. (2016). [The Characteristics of Patients with GIST Who Experienced Late Recurrence after Resection]. Gan To Kagaku Ryoho, 43(12), 2118-2120. 

Valentin, T., Fournier, C., Penel, N., Bompas, E., Chaigneau, L., Isambert, N., & Chevreau, C. (2013). Sorafenib in patients with progressive malignant solitary fibrous tumors: a subgroup analysis from a phase II study of the French Sarcoma Group (GSF/GETO). Invest New Drugs, 31(6), 1626-1627. https://doi.org/10.1007/s10637-013-0023-z 

van der Graaf, W. T., Blay, J. Y., Chawla, S. P., Kim, D. W., Bui-Nguyen, B., Casali, P. G., Schoffski, P., Aglietta, M., Staddon, A. P., Beppu, Y., Le Cesne, A., Gelderblom, H., Judson, I. R., Araki, N., Ouali, M., Marreaud, S., Hodge, R., Dewji, M. R., Coens, C., Demetri, G. D., Fletcher, C. D., Dei Tos, A. P., & Hohenberger, P. (2012). Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet, 379(9829), 1879-1886. https://doi.org/10.1016/s0140-6736(12)60651-5 

Wagner, A. J., Malinowska-Kolodziej, I., Morgan, J. A., Qin, W., Fletcher, C. D., Vena, N., Ligon, A. H., Antonescu, C. R., Ramaiya, N. H., Demetri, G. D., Kwiatkowski, D. J., & Maki, R. G. (2010). Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors. J Clin Oncol, 28(5), 835-840. https://doi.org/10.1200/jco.2009.25.2981

Wang, Y. N., Zhu, W. Q., Shen, Z. Z., Li, S., & Liu, S. Y. (1994). Treatment of locally recurrent soft tissue sarcomas of the retroperitoneum: report of 30 cases. J Surg Oncol, 56(4), 213-216. 

Weimann, A., Braga, M., Carli, F., Higashiguchi, T., Hubner, M., Klek, S., Laviano, A., Ljungqvist, O., Lobo, D. N., Martindale, R., Waitzberg, D. L., Bischoff, S. C., & Singer, P. (2017). ESPEN guideline: Clinical nutrition in surgery. Clin Nutr, 36(3), 623-650. https://doi.org/10.1016/j.clnu.2017.02.013 

Wells, M., Macmillan, M., Raab, G., MacBride, S., Bell, N., MacKinnon, K., MacDougall, H., Samuel, L., & Munro, A. (2004). Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? A randomised controlled trial. Radiother Oncol, 73(2), 153-162. https://doi.org/10.1016/j.radonc.2004.07.032 

Vermaete, N., Wolter, P., Verhoef, G., & Gosselink, R. (2013). Physical activity, physical fitness and the effect of exercise training interventions in lymphoma patients: a systematic review. Ann Hematol, 92(8), 1007-1021. https://doi.org/10.1007/s00277-013-1689-1 

Whelan, J., Le Deley, M. C., Dirksen, U., Le Teuff, G., Brennan, B., Gaspar, N., Hawkins, D. S., Amler, S., Bauer, S., Bielack, S., Blay, J. Y., Burdach, S., Castex, M. P., Dilloo, D., Eggert, A., Gelderblom, H., Gentet, J. C., Hartmann, W., Hassenpflug, W. A., Hjorth, L., Jimenez, M., Klingebiel, T., Kontny, U., Kruseova, J., Ladenstein, R., Laurence, V., Lervat, C., Marec-Berard, P., Marreaud, S., Michon, J., Morland, B., Paulussen, M., Ranft, A., Reichardt, P., van den Berg, H., Wheatley, K., Judson, I., Lewis, I., Craft, A., Juergens, H., & Oberlin, O. (2018). High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008. J Clin Oncol, Jco2018782516. https://doi.org/10.1200/jco.2018.78.2516 

World Health, O., International Agency for Research on, C., & Kurman, R. J. (2014). WHO Classification of Tumours of Female Reproductive Organs [Elektronisk resurs]. International Agency for Research on Cancer. 

Wu, L., Zhang, Z., Yao, H., Liu, K., Wen, Y., & Xiong, L. (2014). Clinical efficacy of second-generation tyrosine kinase inhibitors in imatinib-resistant gastrointestinal stromal tumors: a meta-analysis of recent clinical trials. Drug Des Devel Ther, 8, 2061-2067. https://doi.org/10.2147/dddt.s63840 

Zaikova, O., Sundby Hall, K., Styring, E., Eriksson, M., Trovik, C. S., Bergh, P., Bjerkehagen, B., Skorpil, M., Weedon-Fekjaer, H., & Bauer, H. C. (2015). Referral patterns, treatment and outcome of high-grade malignant bone sarcoma in Scandinavia-SSG Central Register 25 years' experience. J Surg Oncol, 112(8), 853-860. https://doi.org/10.1002/jso.24074 

Zerhouni, S., Van Coevorden, F., & Swallow, C. J. (2018). The role and outcomes of palliative surgery for retroperitoneal sarcoma. J Surg Oncol, 117(1), 105-110. https://doi.org/10.1002/jso.24934 

Se även Bilaga 2 Gynekologiska sarkom.